Meet the sales team

The Company of Biologists has a long-standing commitment to Open Access to support our mission of advancing excellence in the biological and biomedical sciences internationally. Our hybrid journals were the first in the world to be afforded Transformative Journal status by Plan S and we were one of the first not-for-profit publishers to launch a cost-neutral Read & Publish initiative.

Launched in 2019, our Read & Publish initiative continues to go from strength to strength. Over 600 institutions in 41 countries are now participating and we have agreements with many library consortia.

Would you like to find out more about how a Read & Publish agreement can benefit researchers at your institution or institutions in your library consortium? Our friendly and highly experienced sales and subscriptions team are ready to help.